Recent Finacing
Recent Raise
NaNotics is a preclinical biopharmaceutical company developing NaNots—subtractive nanoparticles that capture and clear soluble pathogenic blood molecules while sparing membrane-bound forms.
Focus Areas
Recent Investors
Funding round
Investor
See the team members at NaNotics.
